• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环外泌体 GPC-1 在胰腺癌中的诊断和预后价值:一项荟萃分析。

Diagnostic and prognostic value of circulating exosomal glypican-1 in pancreatic cancer: a meta-analysis.

机构信息

Department of Hepatobiliary Surgery, Dalian Municipal Central Hospital, Dalian, China.

China Medical University, Shenyang, China.

出版信息

Lab Med. 2024 Sep 4;55(5):543-552. doi: 10.1093/labmed/lmae013.

DOI:10.1093/labmed/lmae013
PMID:38470244
Abstract

BACKGROUND

Pancreatic cancer (PC) is usually detected in the advanced stages. Liquid biopsy has become a revolutionary strategy for cancer diagnosis and prognosis prediction. This study aims to investigate the diagnostic and prognostic value of circulating exosomal glypican-1 (GPC-1) in PC.

METHODS

We systematically searched relevant studies. For diagnostic accuracy, pooled sensitivity and specificity and the area under the summary receiver operating characteristic curve (AUC) were calculated. Regarding prognostic value, hazard ratios (HRs) and 95% CIs for overall survival (OS) were summarized by using a random-effects model.

RESULTS

We found 8 studies that examined the diagnostic value of circulating exosomal GPC-1 in PC, and 3 studies that investigated its prognostic value. Pooled sensitivity and specificity were 0.88 (95% CI, 0.65-0.97) and 0.86 (95% CI, 0.72-0.94). The AUC was 0.93 (95% CI, 0.90-0.95). Prognostic analysis showed that higher levels of circulating exosomal GPC-1 were associated with poorer OS in PC patients, and the combined HR for OS was 4.59 (random-effects model, 95% CI = 1.17-18.03, P = .022). The results of both studies were robust and neither had publication bias.

CONCLUSION

Circulating exosomal GPC-1 may be used as a diagnostic and prognostic biomarker for PC. However, this result needs to be validated by further research using a larger sample size.

摘要

背景

胰腺癌(PC)通常在晚期被发现。液体活检已成为癌症诊断和预后预测的革命性策略。本研究旨在探讨循环外泌体糖蛋白聚糖-1(GPC-1)在 PC 中的诊断和预后价值。

方法

我们系统地搜索了相关研究。对于诊断准确性,计算了汇总敏感性和特异性以及汇总受试者工作特征曲线(AUC)下的面积。关于预后价值,使用随机效应模型总结了总生存期(OS)的风险比(HRs)和 95%置信区间(CI)。

结果

我们发现了 8 项研究检测了循环外泌体 GPC-1 在 PC 中的诊断价值,以及 3 项研究调查了其预后价值。汇总敏感性和特异性分别为 0.88(95%CI,0.65-0.97)和 0.86(95%CI,0.72-0.94)。AUC 为 0.93(95%CI,0.90-0.95)。预后分析表明,循环外泌体 GPC-1 水平较高与 PC 患者的 OS 较差相关,OS 的合并 HR 为 4.59(随机效应模型,95%CI=1.17-18.03,P=0.022)。这两项研究的结果都是稳健的,且都没有发表偏倚。

结论

循环外泌体 GPC-1 可能可作为 PC 的诊断和预后生物标志物。然而,这一结果需要通过使用更大的样本量进行进一步研究来验证。

相似文献

1
Diagnostic and prognostic value of circulating exosomal glypican-1 in pancreatic cancer: a meta-analysis.循环外泌体 GPC-1 在胰腺癌中的诊断和预后价值:一项荟萃分析。
Lab Med. 2024 Sep 4;55(5):543-552. doi: 10.1093/labmed/lmae013.
2
A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer.循环外泌体中的微小RNA特征在诊断胰腺癌方面优于外泌体磷脂酰肌醇蛋白聚糖-1水平。
Cancer Lett. 2017 May 1;393:86-93. doi: 10.1016/j.canlet.2017.02.019. Epub 2017 Feb 20.
3
DUPAN-2 in pancreatic cancer: Systematic review and meta-analysis.胰腺癌中的DUPAN-2:系统评价与荟萃分析。
Clin Chim Acta. 2025 Feb 1;567:120080. doi: 10.1016/j.cca.2024.120080. Epub 2024 Dec 7.
4
Systematic review and meta-analysis: diagnostic accuracy of exosomes in pancreatic cancer.系统评价与荟萃分析:外泌体在胰腺癌中的诊断准确性
World J Surg Oncol. 2025 Feb 14;23(1):51. doi: 10.1186/s12957-025-03666-9.
5
Combined Exosomal GPC1, CD82, and Serum CA19-9 as Multiplex Targets: A Specific, Sensitive, and Reproducible Detection Panel for the Diagnosis of Pancreatic Cancer.联合外泌体 GPC1、CD82 和血清 CA19-9 作为多重靶标:一种用于胰腺癌诊断的特异性、灵敏性和重现性检测面板。
Mol Cancer Res. 2020 Feb;18(2):300-310. doi: 10.1158/1541-7786.MCR-19-0588. Epub 2019 Oct 29.
6
Diagnostic value of various liquid biopsy methods for pancreatic cancer: A systematic review and meta-analysis.各种液体活检方法对胰腺癌的诊断价值:一项系统评价和荟萃分析。
Medicine (Baltimore). 2020 Jan;99(3):e18581. doi: 10.1097/MD.0000000000018581.
7
Exosomes as prognostic biomarkers in pancreatic ductal adenocarcinoma-a systematic review and meta-analysis.外泌体作为胰腺导管腺癌的预后生物标志物:系统评价和荟萃分析。
Transl Res. 2022 Jun;244:126-136. doi: 10.1016/j.trsl.2022.01.001. Epub 2022 Jan 20.
8
Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis.循环 miR-21 对癌症的诊断和预后价值:系统评价和荟萃分析。
Gene. 2014 Jan 1;533(1):389-97. doi: 10.1016/j.gene.2013.09.038. Epub 2013 Sep 26.
9
Prognostic value of circulating tumor DNA in pancreatic cancer: a systematic review and meta-analysis.循环肿瘤 DNA 对胰腺癌的预后价值:系统评价和荟萃分析。
Aging (Albany NY). 2020 Dec 9;13(2):2031-2048. doi: 10.18632/aging.202199.
10
Prognostic value of circulating tumor cells in patients with pancreatic cancer: a meta-analysis.循环肿瘤细胞在胰腺癌患者中的预后价值:一项荟萃分析。
Tumour Biol. 2014 Mar;35(3):2473-80. doi: 10.1007/s13277-013-1327-5. Epub 2013 Nov 12.

引用本文的文献

1
Targeting early diagnosis and treatment of pancreatic cancer among the diabetic population: a comprehensive review of biomarker screening strategies.糖尿病患者中胰腺癌的早期诊断与治疗:生物标志物筛查策略的综合综述
Diabetol Metab Syndr. 2025 May 28;17(1):176. doi: 10.1186/s13098-025-01750-4.
2
The diagnostic accuracy of urine-derived exosomes for bladder cancer: a systematic review and meta-analysis.尿液衍生外泌体诊断膀胱癌的准确性:系统评价和荟萃分析。
World J Surg Oncol. 2024 Oct 29;22(1):285. doi: 10.1186/s12957-024-03569-1.